Published in Occup Med (Lond) on February 01, 1996
Lead poisoning: case studies. Br J Clin Pharmacol (2002) 1.04
Dietary strategies for the treatment of cadmium and lead toxicity. Nutrients (2015) 0.88
Protective effect of Thunbergia laurifolia (Linn.) on lead induced acetylcholinesterase dysfunction and cognitive impairment in mice. Biomed Res Int (2013) 0.81
Clinical, toxicological, biochemical, and hematologic parameters in lead exposed workers of a car battery industry. Iran J Med Sci (2013) 0.81
Acute lead intoxication in a female battery worker: Diagnosis and management. J Occup Med Toxicol (2010) 0.79
Toxicant exposure and bioaccumulation: a common and potentially reversible cause of cognitive dysfunction and dementia. Behav Neurol (2015) 0.78
EVALUATION OF THE CHELATING EFFECT OF METHANOLIC EXTRACT OF CORIANDRUM SATIVUM AND ITS FRACTIONS ON WISTAR RATS POISONED WITH LEAD ACETATE. Afr J Tradit Complement Altern Med (2017) 0.75
Reliability of urinary creatinine as a parameter used to adjust values of urinary biological indicators. Int Arch Occup Environ Health (1985) 1.70
Long-term exposure to "low levels" of manganese oxides and neurofunctional changes in ferroalloy workers. Neurotoxicology (1999) 1.56
Trace element reference values in tissues from inhabitants of the European community. I. A study of 46 elements in urine, blood and serum of Italian subjects. Sci Total Environ (1990) 1.33
Neurobehavioral effects of manganese in workers from a ferroalloy plant after temporary cessation of exposure. Scand J Work Environ Health (1995) 1.23
Are current biomarkers suitable for the assessment of manganese exposure in individual workers? Am J Ind Med (2000) 1.19
Problems concerning the usefulness of adjustment of urinary cadmium for creatinine and specific gravity. Int Arch Occup Environ Health (1985) 1.08
Biological monitoring of occupational exposure to inorganic arsenic. Occup Environ Med (1999) 0.99
Brain magnetic resonance imaging and manganese exposure. Neurotoxicology (2000) 0.99
Immune infiltrates and cytokines in gliomas. Acta Neurochir (Wien) (1996) 0.98
Assessment of neurobehavioral performance as a function of current and cumulative occupational lead exposure. Neurotoxicology (2000) 0.96
Indicators of internal dose in current and past exposure to lead. Int Arch Occup Environ Health (1979) 0.96
Na plus-K plus-ATPase activity of erythrocyte membranes: in urban populations not occupationally exposed to lead. Arch Environ Health (1973) 0.94
[Research on the mechanism of inhibition of erythrocyte Na+-K+-ATPase by lead]. Med Lav (1969) 0.94
Neurotoxicity in operating room personnel working with gaseous and nongaseous anesthesia. Int Arch Occup Environ Health (1996) 0.92
Bladder cancer and occupation: a case-control study in northern Italy. Occup Environ Med (1996) 0.92
Implications of metal exposure and liver function in Parkinsonian patients resident in the vicinities of ferroalloy plants. J Neural Transm (Vienna) (2009) 0.90
[Neurotoxic effect of exposure to low doses of mercury]. Med Lav (2002) 0.89
Behaviour of plasma and urinary aluminium levels in occupationally exposed subjects. Int Arch Occup Environ Health (1984) 0.87
Free erythrocyte protoporphyrin as an indicator of the biological effect of lead in adult males. III. Behavior of free erythrocyte protoporphyrin in workers with past lead exposure. Int Arch Occup Environ Health (1976) 0.87
The utility of health education among lead workers: the experience of one program. Am J Ind Med (1993) 0.87
The potencial role of rare earths in the pathogenesis of interstitial lung disease: a case report of movie projectionist as investigated by neutron activation analysis. J Trace Elem Med Biol (2001) 0.86
[Susceptibility to varicella-zoster, measles, rosacea and mumps among health care workers in a Northern Italy hospital]. G Ital Med Lav Ergon (2008) 0.85
Behaviour of biological indicators of internal dose and some neuro-endocrine tests in aluminium workers. Med Lav (1990) 0.84
Chromosome and biochemical studies in women occupationally exposed to lead. Arch Environ Health (1980) 0.84
Free erythrocyte protoporphyrin as an indicator of the biological effect of lead in adult males. II. Comparison between free erythrocyte protoporphyrin and other indicators of effect. Int Arch Occup Environ Health (1976) 0.84
Serum enzymatic activities in experimental lead poisoning. Enzyme (1971) 0.83
Metabolic interferences in subjects occupationally exposed to binary styrene-acetone mixtures. Int Arch Occup Environ Health (1998) 0.83
[Hematological changes in 2 workers occupationally exposed to chloramphenicol]. Med Lav (1972) 0.83
[Occupational exposure to drugs. General considerations]. Med Lav (1976) 0.82
Multiple exposure to arsenic, antimony, and other elements in art glass manufacturing. Am J Ind Med (1998) 0.81
Free erythrocyte protoporphyrin as an indicator of the biological effect of lead in adult males. I. Relationship between free erythrocyte protoporphyrin and indicators of internal dose of lead. Int Arch Occup Environ Health (1976) 0.81
Urinary cobalt excretion in short time occupational exposure to cobalt powders. Sci Total Environ (1994) 0.80
Metastasis to intracranial meningioma as first clinical manifestation of occult primary lung carcinoma. Tumori (1996) 0.80
[Conditions of hypersusceptibility in subjects occupationally exposed to inorganic lead]. Med Lav (1978) 0.80
Significance and validity of a shortened lead chelation test. J Occup Med (1990) 0.80
Primary intrasellar coccidioidomycosis simulating a pituitary adenoma. Neurosurgery (1991) 0.80
[Tuberculin skin test (TST) survey among healthcare workers (HCWs) in hospital: a systematic review of the literature]. G Ital Med Lav Ergon (2008) 0.79
Behaviour of aluminium in plasma, erythrocytes and urine in non-occupationally exposed subjects. Med Lav (1986) 0.79
Electrophoretic characterization of glucose-6-phosphate dehydrogenase (G6PD) in granulocytes and lymphocytes of normal and fava bean-sensitive subjects. Clin Chim Acta (1969) 0.79
Metabolism of arsenic after acute occupational arsine intoxication. J Toxicol Environ Health (1997) 0.79
[Hepatic cirrhosis and porphyria cutanea tarda in a subject occupationally exposed to methyl chloride]. Med Lav (1983) 0.78
Behaviour of indicators of exposure and effect after cessation of occupational exposure to lead. Br J Ind Med (1981) 0.78
Clinical and virological characteristics associated with severe acute hepatitis B. Clin Microbiol Infect (2014) 0.78
Occupational exposure to cadmium and lung function. IARC Sci Publ (1992) 0.78
Occupational exposure to nalidixic acid. Br Med J (1972) 0.77
International project for producing reference values for concentrations of trace elements in human blood and urine--TRACY. Scand J Work Environ Health (1993) 0.77
Meningeal melanocytoma: a rare lesion of the central nervous system. Tumori (1997) 0.77
Interferences of urinary tract infection in the measurement of urinary nitrous oxide. Occup Environ Med (1996) 0.77
[Exposure to neurotoxic metals and prevalence of parkinsonian syndrome in the area of Brescia]. G Ital Med Lav Ergon (2004) 0.77
Behaviour of urinary nickel in low-level occupational exposure. Med Lav (1989) 0.77
[Occupational cancer. The role of the occupational physician in systematic search and aetiological diagnosis of lung cancer. Analysis of a case list]. Med Lav (2006) 0.77
Mechanism of neurobehavioral alteration. Toxicol Lett (2000) 0.76
Behaviour of urinary beryllium in general population and in subjects with low-level occupational exposure. Med Lav (1990) 0.75
Ambulatory blood pressure monitoring in clinically healthy subjects adapted to living in Antarctica. Aviat Space Environ Med (1997) 0.75
[The central role of the specialized physician in preventive care]. Med Lav (2014) 0.75
[Biological monitoring of occupational exposure to aluminum]. Med Lav (1993) 0.75
[Latex allergy in health care workers: frequency, exposure quantification, efficacy of criteria used for job fitness assessment]. Med Lav (2004) 0.75
[Organization of health and safety activities in health care centers]. Med Lav (2000) 0.75
The death of Prof. Enrico Vigliani. Med Lav (1992) 0.75
[Protocol for health surveillance of workers exposed to repetitive arm movements]. Med Lav (2003) 0.75
[The health surveillance of personnel who handle antineoplastic agents]. Med Lav (1996) 0.75
[Prevalence of carpal tunnel syndrome in workers executing complex tasks with the upper extremities]. Med Lav (2000) 0.75
[Does the decree 25/2002 still guarantee the health care of workers exposed to lead?]. G Ital Med Lav Ergon (2003) 0.75
Occupational exposure to pectinase. Allergy (2002) 0.75
Effects of four inorganic lead compounds on the proliferation and junctional coupling of cultured REL liver cells. Am J Ind Med (2000) 0.75
[Health surveillance: scope, tools, efficacy, prospects]. G Ital Med Lav Ergon (2000) 0.75
[Skin disorders and job fitness assessment]. Med Lav (2002) 0.75
[Effects on hearing in exposure to impulsive and high frequency noise]. Med Lav (1992) 0.75
[The stress index: proposed method for risk assessment of stress and burnout in health care settings]. G Ital Med Lav Ergon (2004) 0.75
[Lead in the 90's: "new" rules for the "oldest" of environmental toxins?]. Med Lav (1993) 0.75
[A report of 3 cases of pleural mesothelioma with unusual asbestos exposure]. Med Lav (2000) 0.75
[Round Table "Role of scientific and professional associations in proposing occupational health programs to regional and national authorities]. G Ital Med Lav Ergon (2000) 0.75
Ten-year follow-up of biological monitoring of cadmium-exposed workers. IARC Sci Publ (1992) 0.75
[The evaluation of occupational exposure to carcinogenic substances: limit values and risk assessments]. G Ital Med Lav (1993) 0.75
Daily hunger sensation monitoring as a tool for investigating human circadian synchronization. Eat Weight Disord (2000) 0.75
[What are the prospects of metal toxicology studies?]. Med Lav (1991) 0.75
[Cooperation between the occupational health department and the technical assistance office to confront the problem of pollution by anesthetics]. G Ital Med Lav (1994) 0.75
Neurobehavioral functions in operating theatre personnel exposed to anesthetic gases. Med Lav (1995) 0.75
[Proposal of a health education program]. G Ital Med Lav (1994) 0.75
[Seropositivity and the work place. A problem which requires cooperation of the labor physician and the infection specialist]. Med Lav (1991) 0.75
Increases in polycyclic aromatic hydrocarbon content and mutagenicity in a cutting fluid as a consequence of its use. Int Arch Occup Environ Health (1993) 0.75
Urinary mutagenicity tests in lead-exposed workers. Mutat Res (1989) 0.75
Proposal of a method for identifying exposure to hazardous chemicals in biomedical laboratories. Clin Chim Acta (1996) 0.75
[Evaluation of the dose of mercury in exposed and control subjects]. Med Lav (2002) 0.75
Multiple exposure to metals in eight types of welding. G Ital Med Lav Ergon (1998) 0.75
[A pilot study on training and information of workers exposed to biomechanical overload of the upper limb]. G Ital Med Lav Ergon (2001) 0.75
[Changes in isoenzymatic fractions of erythrocyte lactate-dehydrogenase (LDH) in lead poisoning anemia. 1968]. Med Lav (2002) 0.75
Manganese effects on the human neuroblastoma cell line SK-ER3. Toxicol Appl Pharmacol (1996) 0.75
[Medical surveillance and occupational identification of workers exposed to repeated movements of the upper limbs]. G Ital Med Lav Ergon (2001) 0.75
[Assessment of exposure to polycyclic aromatic hydrocarbons in 3 work activities using mineral oils]. G Ital Med Lav (1990) 0.75
[Qualitative and quantitative changes in the polycyclic aromatic hydrocarbons in cutting oils after their use]. G Ital Med Lav (1989) 0.75
Folliculo-stellate cells of human pituitary adenomas: immunohistochemical study of the monocyte/macrophage phenotype expression. Neuroendocrinology (1997) 0.75
[Protein content of latex gloves used in hospitals]. G Ital Med Lav Ergon (2003) 0.75
[Risk of exposure to metals in the production and processing of copper alloys]. Med Lav (1992) 0.75
[Evaluation of the effects of reduced glutathione in subjects with acquired and congenital changes in heme biosynthesis]. Minerva Med (1992) 0.75
[Significance of biological indicators of mercury exposure]. Med Lav (2003) 0.75
[Clinical, genetic and biochemical findings on some hemoglobinopathies (Hb H-microcythemia; Hb Cagliari-microcythemia) in the Sardinian population]. Minerva Med (1966) 0.75
Evaluation of beta-endorphin/beta-lipotropin immunoreactivity content in the CSF of patients affected by deafferentation pain syndromes. Pharmacol Res (1991) 0.75